The company, which focuses on developing exoskeletons, plans to list on the NASDAQ under the symbol RWLK. Barclays and Jefferies acted as joint bookrunners on the deal, according to the report.
More articles on devices:
LifeScience Alley honors Zimmer’s Virage OCT Spinal Fusion System
5 key concepts on Zyga Technology’s $10M financing
Stryker looks to expand facility
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
